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Abstract
A presacral mass can present a diagnostic dilemma for the surgical oncologist. Differential
diagnoses include congenital causes such as teratoma or chordoma, neurological causes such as
neurilemoma or neurofibroma or other malignancies such as lymphoma or sarcoma. Diagnosis
usually requires imaging such as CT and MRI and tissue biopsy. We present an unusual cause of a
presacral mass being extramedullary haematopoiesis, found incidentally in a 71 year old female.
Extramedullary haematopoiesis is defined as the production of myeloid and erythroid elements
outside of the bone-marrow. This diagnosis is extremely rare in the presacral area especially in a
patient with no haematological abnormalities. A review of the literature is presented.
Background
Extramedullary haematopoiesis (EH) is defined as the
production of myeloid and erythroid elements outside of
the bone-marrow. It is usually a mechanism to compen-
sate for haemolytic anaemia such as spherocytosis or tha-
lassaemia, or as a response to abnormal bone-marrow
function seen in disorders such as myelofibrosis or leu-
kaemia [1-4].
Approximately only 5% of cases of EH occur outside of
the liver and spleen. Of these, the most common sites are
surrounding the vertebral column (especially the thoracic
region), lymph nodes, retroperitoneum, lung and pleura
[1]. Other sites include gastrointestinal tract, brain, kidney
and adrenal glands [2,4-6].
The differential diagnosis of a presacral mass can be cate-
gorized as congenital (65%), neurogenic (12%), osseous
(11%) or miscellaneous (12%). Congenital causes are the
most common and include causes such as epidermoid
cyst and teratoma, especially in females and chordomas
especially in males. Developmental cysts tend to occur in
middle-age, are associated with anorectal malformation
and sacral bone defects and are generally benign. They are
usually asymptomatic, but can become infected, causing
pain and discomfort. Other symptoms are associated with
mass effect, occasionally causing bowel and bladder
symptoms[7]. Teratomas can cause pain and pre-anal
drainage in their late stages. In an adult population they
are usually benign, as opposed to their paediatric counter-
part[7]. Chordomas arise from primitive notochordal
remnants. They present with pain and often with bowel
and bladder symptoms due to autonomic dysfunction.
They grow slowly, but do invade into local bone and soft-
tissue. Excision is the mainstay of treatment.
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Neurogenic causes of a presacral mass include neurilem-
omas (Schwanommas) or neurofibromas. Neurilemomas
are rare and present with nonspecific symptoms and radi-
ological findings. They can look cystic on imaging. Full
excision is recommended as they have a high recurrence
with other forms of treatment. They tend to be benign
with minimal metastatic potential[8].
Lymphoma, sarcoma and giant cell tumours account for
other more common causes [9]. Solid lesions should
arouse suspicion of malignancy [10]. Due to the serious-
ness of some of these differential diagnoses, correct iden-
tification of the pathology is mandatory.
Case
A 71 year old female was referred for investigation of a
presacral mass found incidentally during a staging CT (fig-
ure 1) and MRI (figure 2) of a recently diagnosed rectal
carcinoma. The mass was located anterior to S4 and S5 in
the presacral space. She was completely asymptomatic of
this mass. Except for the recently diagnosed rectal carci-
noma and hypertension, she had no other medical issues.
Her CT scan revealed a suggestion of an ill-defined presac-
ral mass, reported as possible oedema. The subsequent
staging MRI clarified a 3.3 × 1.9 × 2.3 cm presacral mass at
the level of S4/S5. Evidence of bony erosion could not be
seen.
Initially, differential diagnoses for this mass included
chordoma, schwannoma and plasmacytoma. The mass
was further investigated with a whole body thallium study
and a CT-guided biopsy (figure 3). The thallium study
revealed no evidence of a thallium avid tumour in the sac-
rum or elsewhere. The biopsy revealed fat and haemat-
opoietic tissue, consistent with a diagnosis of
extramedullary haematopoiesis (figure 4 and 5). The
occurrence of EH in the presacral area is an extremely rare
finding with only 17 reported cases in the literature.
This remarkable diagnosis was further investigated with
the help of a haematologist. A full history found no per-
sonal or family history of bleeding disorders or anaemia.
Full blood examination and liver function tests revealed
no abnormality. A bone marrow biopsy was taken which
revealed mildly hypercellular marrow, showing a mild
increase in trilineage haemopoiesis. This was likely to be
reactive. A cytogenetics study was organized to differenti-
ate reactive marrow from early myelodysplasia. No
cytogenetic abnormality was detected.
The case was discussed at a multi-disciplinary meeting
and a decision was made that this mass was benign in
nature. No further investigations or treatment was
deemed necessary. The patient subsequently underwent
an uncomplicated resection of her rectal carcinoma. This
is only the second case reported in the literature of a pres-
caral site of extramedullary haematopoiesis with no obvi-
ous underlying cause.
MRI Sagittal view of lesion Figure 2
MRI Sagittal view of lesion.
CT transverse view of lesion showing 33.52 mm diameter  lesion in the presacral area Figure 1
CT transverse view of lesion showing 33.52 mm 
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Discussion
In the literature, the majority of the cases of presacral EH
were found incidentally (Table 1. Seven of the cases
reported where asymptomatic, and were only discovered
during investigation of an unrelated disorder [3,5,6,11-
13]. Of the rest, four presented with pain [2,14-16], one
presented with constipation [17], one presented with
symptoms of anaemia [4] and one presented with a pelvic
mass [11]. The presenting complaints of the remaining 3
cases could not be identified[18]. A digital rectal exam is
very helpful in identifying a presacral mass as a cause of
vague symptoms of pain and bowel and bladder dysfunc-
tion. Almost all presacral lesions causing symptoms can
be detected in this way[7,9].
A CT-scan is a common preliminary investigation. EH
usually appears as heterogeneous lobulated solid mass
with smooth margins. Its density is similar to that of soft-
tissue, slightly denser than fluid [2,4,16]. Other CT find-
ings that may indicate EH as a cause include hepatomeg-
aly or splenomegaly, consistent with common sites of EH
[5,19,20]. Based on CT imaging, a differential diagnosis is
lymphoma, which tends to produce a pattern of retroperi-
toneal involvement of lymph nodes surrounding the great
vessels [19,20]. Radiolucency in the sacral area can indi-
cate bony pathology such as osteoid osteoma, chordoma
or sarcoma[7].
An MRI of presacral EH often reveals a characteristic well
encapsulated tumour with a slightly higher signal inten-
sity than muscle on T1 and T2 weighted imaging, consist-
ent with fatty tissue [2,21]. There is usually no evidence of
communication between the mass and neural struc-
tures[13]. The mass becomes uniformly enhanced after
gadolinium injection [2,16]. Possible iInvolvement of the
ureters, rectum and pelvic vessels should be explored
when reviewing the MRI.
Nuclear imaging using a whole body scan post intrave-
nous administration of Tc-99m sulfur colloid revealing
increased uptake within the site of the mass is also consist-
ent with EH[11,15]. This test can also expose other sites of
EH within the body[11]. Angiography can be helpful due
to the hypervascularity of these lesions. Homogeneous
enhancement post contrast angiography indicates the
possibility of EH [22].
Fat and haematopoietic tissue consistent with extramedullary  haematopoiesis Figure 5
Fat and haematopoietic tissue consistent with 
extramedullary haematopoiesis.
CT guided biopsy through presacral lesion using posterola- teral approach Figure 3
CT guided biopsy through presacral lesion using pos-
terolateral approach.
Histological findings of extramedullary haematopoiesis on  biopsy Figure 4
Histological findings of extramedullary haematopoie-
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With any mass, a tissue sample is usually considered
essential to correct diagnosis. The presacral location
presents a technical challenge to obtaining such a sample.
Possible complications associated with a biopsy of this
region include infection and bleeding, especially resulting
from insult to the middle sacral artery[10]. Hence, one
author suggests that a biopsy should only be attempted in
solid lesions with malignant features such as sacral inva-
sion. Biopsy of a cystic lesion has a higher risk of subse-
quent infection [10]. If a biopsy is to be attempted, the
Table 1: Patient list: cases of presacral extramedullary haematopoiesis reported in the literature.
Author Year 
published
Age of patient Symptoms Diagnosis Predisposing 
factors
Management Outcome
Babazadeh 2009 71 F None, found 
incidentally
CT, MRI, Biopsy 
(Bx)
None identified Conservative No change
Gupta [3] 2008 79 M None CT, MRI Spherocytosis Conservative No change after 
3 years
Saur [4] 2007 83 F Anaemia CT, Bx Myelofibrosis Conservative Not known





Sacral fracture Excision Not known
Youngster [16] 2006 48 F Painful 








Excision Symptom free 
at 12 months
Al-aabassi [6] 2005 23 F None, found 
incidentally








Sarmiento [5] 2003 69 M None, found 
incidentally
CT, Bx Spherocytosis Conservative No change at 1 
year. Bloods 
normal














time, mass still 
present at 6 
months
Karak [15] 1998 68 F Lower back pain TC-99, Bx None identified Conservative Not known




Chao [17] 1986 Unknown Constipation CT Beta 
thalassaemia
Not known Not known
Sebes [11] 1984 46 F None, found 
incidentally
Tc-99, CT Sickle Cell 
anaemia
Not known Not known
Sebes [11] 1984 35 F Pelvic mass Tc-99, CT Beta 
thalassaemia 
intermedia
Excision Not knownInternational Seminars in Surgical Oncology 2009, 6:18 http://www.issoonline.com/content/6/1/18
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needle tract should be in a position that can be excised en-
bloc with the mass if excision is required. Possible routes
of access include transgluteal, transrectal, transacral, par-
asacral and precoccygeal approaches[10]. Histological
examination of a biopsy consistent with EH reveals
hematopoietic cells with polymorphous infiltrates includ-
ing megakaryocytes and lymphocytes [4,12,13,15]. Mac-
roscopic features of EH includes a soft, fatty tumour,
usually adherent to adjacent structures, revealing an ery-
thematous cut surface [4,12,13,16].
Literature regarding the management of such a condition
is limited due to its rarity. Of the reported cases 5 were
treated conservatively and monitored, with none report-
ing an adverse outcome [2-5]. Four patients underwent
surgical excision, all reporting good results with no com-
plications [11-13,16]. One patient was treated with regu-
lar blood transfusions in an attempt to reduce the need for
an extramedullary site for haematopoiesis [6]. One
patient was treated with radiotherapy, resulting in symp-
tomatic relief[14]. The management and outcomes of the
remaining patients is unclear. Most authors agree that no
treatment is necessary unless the patient is symptomatic
[3,4,6,12,13,16]. In symptomatic patients, radiotherapy is
recommended as a non-invasive and highly effective treat-
ment for EH[1,4]. Other non-invasive forms of treatment
include the use of iron chlation with desferrioxamine to
relieve anaemia and suppress EH[6], or hydroxyurea to
enhance foetal haemoglobin production[23]. Although
surgical excision is not usually required in asymptomatic
patients, it is often performed due to the sinister nature of
the differential diagnoses. Adherence to surrounding tis-
sue can make surgical excision difficult and potentially
hazardous.
The prognosis of presacral EH is highly reliant on the
underlying cause. All cases with reported follow-up had a
satisfactory outcome, with those requiring excision for
symptoms remaining symptom free[16], and those
treated conservatively, remaining stable[3,5]. One patient
who suffered sciatic type pain as a result of the tumour
became symptom free within six months, with follow-up
exams showing the tumour had decreased in size[2]. A
hypothesis explaining this reduction in size is fatty trans-
formation of the mass[24]. Sclerotic tumours may predict
a poor prognosis, indicating end-stage myeloproliferative
disease[25]. Sacral destruction or symptomatic disease
indicates a possible malignant cause and should be inves-
tigated fully[26].
Conclusion
Extramedullary haematopoiesis as a diagnosis for a pre-
sacral mass is rare. It is usually asymptomatic and hence
typically discovered incidentally. It is heavily associated
with haematological disorders, especially myleodysplasia
and thalassaemia. A tissue biopsy is generally performed
to differentiate this diagnosis from other, more sinister
conditions that are more common in this region. Once a
diagnosis is made, it is considered safe to treat these
lesions conservatively in an asymptomatic patient. In a
symptomatic patient, the mass may either be excised or
radiotherapy used to shrink its presence.
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